Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q2 FY2022 Earnings Presentation
18 slides from Clean Science & Technology's earnings presentation, November 2021
Slide 1: Stock exchange filing letter: Investor Presentation
Clean Science arrd Technology Limited innovotion of work Datc: I l.ll.202l I'o, BSE Limited National Stock Exchange of India Limited Plr i rozc .lce.leebhoy'l'clwers. Exchange Plaza, Plot no. C/l, Dalal Street. G Block, Bandra-Kurla Complex Irolt. Bandra (E), Munrbai 400 001 Mumbai - 400 051 Scrip C
Slide 2: Q2 FY 2022 Results Presentation
Q2 FY 2022 RESULTS PRESENTATION November 2021
Slide 3: Updates for the Quarter 2, FY2022
UPDATES FOR THE QUARTER 2, FY2022
Slide 4: Key Updates During the Quarter
KEY UPDATES DURING THE QUARTER Resilient quarterly performance and steadfast commitment towards capex Resilient • Despite steep increase in raw material prices, gross margins for Q2 FY2022 remained healthy at ~ 68% performance Price of key inputs (INR/kgs) much higher than pre-Covid levels and have
Slide 5: P&L Overview – Steady Revenues and Resilient Margin
P&L OVERVIEW – STEADY REVENUES AND RESILIENT MARGIN Key short term concerns: steep increase in input prices, logistical challenges Particulars Q2 Q1 Q-o-Q Q2 Y-o-Y H1 H1 Y-o-Y (INR Crore) FY 2022 FY 2022 (%) FY 2021 (%) FY 2022 FY 2021 (%) Revenue from product sales 151.7 144.7 5% 138.9 9% 296.3 250
Slide 6: Balance Sheet Summary
BALANCE SHEET SUMMARY Lean working capital cycle of 60 days and nil debt In INR Crore As at 30 Sept. 2021 As at 31 March 2021 Assets Fixed Assets 233.4 182.9 Capital work-in-progress 41.7 55.0 Right of use asset 14.0 3.0 Other non-current assets 20.4 25.0 Total non-current assets 309.5 265.9 Key met
Slide 7: Sales Profile – H1 FY22
SALES PROFILE – H1 FY22 Key segments delivering encouraging performance; export markets continue to remain strong Revenue mix by segment Revenue mix by geography 112.6 96.4 H1 FY22 H1 FY21 22.3 7% 6% 19.7 17.1 18.9 15% 13% Performance Chemicals Pharma Chemicals FMCG Chemicals 15% 19% Q2 FY22 Q2 FY21
Slide 8: Corporate Presentation
CORPORATE PRESENTATION
Slide 9: Company Evolution
COMPANY EVOLUTION Focus on R&D and innovation has led to new product launches on a consistent basis • In line with our vision, • Started manufacturing • Started manufacturing • Started changed name to 4-MAP Anisole using liquid phase manufacturing DCC Clean Science and Technology technology 2009 201
Slide 10: Key Differentiators
KEY DIFFERENTIATORS Helped company develop into a global supplier of critical specialty chemicals in just 15 years Among the largest Multiple, automated Unique, innovative, producers globally of manufacturing facilities sustainable and cost- critical specialty with zero liquid discharge effective ca
Slide 11: Strong In-House R&D
STRONG IN-HOUSE R&D Pioneered commercialization of catalytic-reactions in production processes • Designing catalysts to create new manufacturing processes and new products R&D • Develop eco-friendly processes by eliminating use of toxic starting materials Strategy • Focus on good Atom economy to avo
Slide 12: Technocrat Promoters
TECHNOCRAT PROMOTERS Promoters’ sole business interest remains Clean Science and Technology with 78.51% stake Ashok Boob Over 25 years of work experience in the chemical industry. Managing Director B.Chem. Engg. - ICT, Previously worked as an Executive Director at Mangalam Drugs Mumbai, India Key fu
Slide 13: Robust Corporate Governance
ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market reviewers Pradeep Rathi Prof. G. D. Yadav Sanjay Kothari Chairman and Non-Executive Director Non-Executive, Non-Executive Director Independent Director B.Sc, M.S. (MIT, USA), MBA (Columbia, USA) B.Chem. Enginee
Slide 14: Diversified Product Profile
DIVERSIFIED PRODUCT PROFILE With applications across various critical end-user industries PRODUCT APPLICATION REVENUE (INR Crore) PERFORMANCE CHEMICALS FY 2021 355 • Polymerization inhibitor in acrylic acids, acrylic esters, super MEHQ (Monomethyl ether absorbent polymers (diapers and sanitary pad
Slide 15: FY 2021 Revenue Contribution
FY 2021 REVENUE CONTRIBUTION Diversified customer base and wide product applications across industries BY SEGMENT BY GEOGRAPHY 6% 12% 13% 1% 16% 31% 37% 70% 14% Performance Chemicals Pharmaceutical FMCG Others Americas China Europe India Row • Strong customer relationships and presence in export mar
Slide 16: Strong Financials
STRONG FINANCIALS Among the fastest growing and profitable specialty chemical companies globally EBITDA & EBITDA% 2,500PAT & PAT% 50% REVENUE EBITDA CAGR of 52% PAT CAGR of 59% 39% CAGR of 28% 2,000 40% 3,000 51% 60% 33% 512 2,500 44% 50% 1,500 25% 30% 393 419 35% 20% 2,000 30% 40% 1,500 30% 1,000 1
Slide 17: Commitment Towards ESG
COMMITMENT TOWARDS ESG ENVIRONMENT (E) SOCIAL (S) CORPORATE GOVERNANCE (G) Among the few companies globally Total contribution towards CSR activities More than 1/3rd Board members are focused on developing “green”, eco- during last 3 years is INR 8.1 crore independent friendly & cost competiti
Slide 18: Disclaimer
DISCLAIMER Certain statements and opinions with respect to the anticipated future performance of the company in the presentation (“forward - looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Such
Clean Science and Technology — Q2 FY2022 Earnings Presentation on 6ix